CD4 and diabetes mellitus: The utility of this measurement is demonstrated by our patient with a novel missense variant in the alternatively spliced exon two who had isolated diabetes at age 5 years but in whom the TSDR/CD4 value was raised leading to reclassification of the variant as likely pathogenic.